A 65-year-old woman with atrial fibrillation (not on anticoagulation) presents with acute left-sided weakness and aphasia. CT head shows a right-sided lobar hemorrhage (35 mL) without intraventricular extension or midline shift. GCS is 15, BP is 165/95 mmHg. What is the most appropriate immediate next step?

Explanation

## Clinical Context This patient has a supratentorial lobar ICH of moderate size without features requiring emergent surgery (no IVH, no midline shift, GCS 15). The priority is acute blood pressure management and ICU-level monitoring. ## Key Point: **Acute blood pressure lowering to SBP < 140 mmHg within the first hour reduces hematoma expansion and improves outcome in ICH.** This is the cornerstone of acute ICH management in hemodynamically stable patients without surgical indications. ## Blood Pressure Management in ICH | Target | Rationale | Timing | |--------|-----------|--------| | SBP < 140 mmHg | Reduces hematoma expansion (INTERACT-2 trial) | Within 1 hour of symptom onset | | Mean arterial pressure (MAP) reduction | Avoid excessive lowering (risk of ischemic stroke) | Titrate to target | | Preferred agents | IV labetalol, nicardipine, hydralazine | Rapid-acting, titratable | **High-Yield:** The INTERACT-2 trial (2013) demonstrated that intensive BP lowering (target SBP < 140 mmHg) in acute ICH reduces hematoma expansion and improves functional outcomes compared to standard management. ## Management Algorithm for Lobar ICH (35 mL, GCS 15) ```mermaid flowchart TD A[Lobar ICH, 35 mL, GCS 15]:::outcome --> B{Surgical indications present?}:::decision B -->|IVH, midline shift, herniation| C[Urgent neurosurgery consult]:::urgent B -->|No| D[ICU admission]:::action D --> E[IV antihypertensive therapy]:::action E --> F[Target SBP < 140 mmHg within 1 hour]:::action F --> G[Continuous monitoring, serial CT if deterioration]:::action A --> H{Underlying lesion suspected?}:::decision H -->|Yes - lobar location, young age| I[CTA/MRI after stabilization]:::action H -->|No| J[Standard ICH protocols]:::action ``` ## Why NOT the Other Options? **Clinical Pearl:** Anticoagulation (warfarin, DOAC) should NOT be started acutely in ICH, even in patients with atrial fibrillation. Anticoagulation increases hematoma expansion risk. Anticoagulation is typically deferred for 7–14 days (depending on ICH severity and bleeding risk), then reintroduced with careful monitoring. **Key Point:** CTA and MRI are useful to identify underlying structural lesions (aneurysm, AVM, tumor) in lobar ICH, but they should NOT delay acute BP management. These imaging studies are obtained *after* stabilization and ICU admission. ## Supportive ICH Management 1. Head of bed 30°, midline head position 2. Normothermia (avoid fever—associated with worse outcomes) 3. Normoxia and normocapnia 4. Seizure prophylaxis: levetiracetam 500 mg BD (reduces seizure risk by ~50%) 5. DVT prophylaxis: sequential compression devices (avoid anticoagulation acutely) 6. Glucose control: maintain 140–180 mg/dL (hyperglycemia worsens outcome) 7. Avoid hyperthermia and hypoxia ## When to Consider Neurosurgery - Hematoma volume > 30 mL in lobar/cerebellar location *with* deterioration or mass effect - Intraventricular hemorrhage with hydrocephalus (EVD) - Cerebellar ICH > 3 cm (high risk of brainstem compression) - Acute subdural hematoma with midline shift [cite:Harrison 21e Ch 296; Robbins 10e Ch 28]